Back
Probe Gold, Inc. Vs. Rigel Pharmaceuticals, Inc. Industry Stock Comparison
Buy
63
PROBF
Probe Gold, Inc.
Last Price:
$2.64
Seasonality Move:
24.14%
Buy
72
RIGL
Rigel Pharmaceuticals, Inc.
Last Price:
$41.63
Seasonality Move:
-1.35%
Buy
63
Probe Gold, Inc. (PROBF)
is a Buy
Is Probe Gold, Inc. a Buy, Sell or Hold?
-
The current Probe Gold, Inc. [PROBF] share price is $2.64. The Score for PROBF is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
PROBF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
72
Rigel Pharmaceuticals, Inc. (RIGL)
is a Buy
Is Rigel Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rigel Pharmaceuticals, Inc. [RIGL] share price is $41.59. The Score for RIGL is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
-
RIGL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PROBF Stock Price Chart
What is Probe Gold, Inc.'s stock price today?
-
The Probe Gold, Inc. share price today is $2.64Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PROBF is experiencing slight selling pressure.
RIGL Stock Price Chart
What is Rigel Pharmaceuticals, Inc.'s stock price today?
-
The Rigel Pharmaceuticals, Inc. share price today is $41.59Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RIGL is experiencing selling pressure, which indicates risk of future bearish movement.
PROBF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.5 | Buy |
| Relative Strength Index (14 RSI): | 60.4 | Buy |
| Chaikin Money Flow: | -56770 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.59 - 2.65) | Buy |
| Bollinger Bands (100): | (1.8 - 2.54) | Buy |
RIGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.85 | Buy |
| Relative Strength Index (14 RSI): | 48.4 | Sell |
| Chaikin Money Flow: | -1420728 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.45 - 47.99) | Sell |
| Bollinger Bands (100): | (29.17 - 43.09) | Buy |
PROBF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.65 | Sell |
| 20-day SMA: | 2.63 | Buy |
| 50-day SMA: | 2.44 | Buy |
| 200-day SMA: | 1.86 | Buy |
| 8-day EMA: | 1.4 | Buy |
| 20-day EMA: | 0.68 | Buy |
| 50-day EMA: | 0.3 | Buy |
| 200-day EMA: | 0.08 | Buy |
RIGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.73 | Sell |
| 20-day SMA: | 45.09 | Sell |
| 50-day SMA: | 38.13 | Buy |
| 200-day SMA: | 27.66 | Buy |
| 8-day EMA: | 22.1 | Buy |
| 20-day EMA: | 10.83 | Buy |
| 50-day EMA: | 4.72 | Buy |
| 200-day EMA: | 1.23 | Buy |
Probe Gold, Inc. Earnings Growth & PROBF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rigel Pharmaceuticals, Inc. Earnings Growth & RIGL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.13 per share, and a decrease next year of $2.31 per share.
Probe Gold, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rigel Pharmaceuticals, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||